Biography

Prof. Kyoko Tsukiyama-Kohara

Transboundary Animal Diseases Center
Department of Animal Hygiene
Joint Faculty of Veterinary Medicine
Kagoshima University, Japan


Email: kkohara@agri.kagoshima-u.ac.jp, kkohara@vet.kagoshima-u.ac.jp


Qualifications

1989 Ph.D., Agriculture, Tokyo University, Tokyo

1985 M.Sc., Veterinary Medicine, Hokkaido University, Japan

1983 B.Sc., Veterinary Medicine, Hokkaido University, Japan


Publications  (selected)

  1. Kayesh, M. E. H., Kohara, M., & Tsukiyama-Kohara, K. (2024). Recent Insights into the Molecular Mechanisms of the Toll-like Receptor Response to Influenza Virus Infection. International Journal of Molecular Sciences, 25(11), 5909.
  2. Kayesh, M. E. H., Khalil, I., Kohara, M., & Tsukiyama-Kohara, K. (2023). Increasing dengue burden and severe dengue risk in Bangladesh: an overview. Tropical Medicine and Infectious Disease, 8(1), 32.
  3. Kayesh, M. E. H., Kohara, M., & Tsukiyama-Kohara, K. (2023). TLR agonists as vaccine adjuvants in the prevention of viral infections: An overview. Frontiers in microbiology, 14, 1249718.
  4. Kayesh, M. E. H., & Tsukiyama-Kohara, K. (2022). Mammalian animal models for dengue virus infection: a recent overview. Archives of virology, 1-14.
  5. Kayesh, M. E. H., Kohara, M., & Tsukiyama-Kohara, K. (2021). An overview of recent insights into the response of TLR to SARS-CoV-2 infection and the potential of TLR agonists as SARS-CoV-2 vaccine adjuvants. Viruses, 13(11), 2302.
  6. Saito, M., Itoh, Y., Yasui, F., Munakata, T., Yamane, D., Ozawa, M., ... & Kohara, M. (2021). Macrocyclic peptides exhibit antiviral effects against influenza virus HA and prevent pneumonia in animal models. Nature communications, 12(1), 2654.
  7. Suzuki, Y., Onuma, H., Sato, R., Sato, Y., Hashiba, A., Maeki, M., ... & Harashima, H. (2021). Lipid nanoparticles loaded with ribonucleoprotein–oligonucleotide complexes synthesized using a microfluidic device exhibit robust genome editing and hepatitis B virus inhibition. Journal of controlled release, 330, 61-71.
  8. Kayesh, M. E. H., Kohara, M., & Tsukiyama-Kohara, K. (2021). Toll-like receptor response to hepatitis B virus infection and potential of TLR agonists as immunomodulators for treating chronic hepatitis B: an overview. International Journal of Molecular Sciences, 22(19), 10462.
  9. Ezzikouri, S., Nourlil, J., Benjelloun, S., Kohara, M., & Tsukiyama-Kohara, K. (2020). Coronavirus disease 2019—Historical context, virology, pathogenesis, immunotherapy, and vaccine development. Human vaccines & immunotherapeutics, 16(12), 2992-3000.
  10. Kayesh, M. E. H., Amako, Y., Hashem, M. A., Murakami, S., Ogawa, S., Yamamoto, N., ... & Tsukiyama-Kohara, K. (2020). Development of an in vivo delivery system for CRISPR/Cas9-mediated targeting of hepatitis B virus cccDNA. Virus Research, 290, 198191.
  11. Kitab, B., Satoh, M., Ohmori, Y., Munakata, T., Sudoh, M., Kohara, M., & Tsukiyama-Kohara, K. (2019). Ribonucleotide reductase M2 promotes RNA replication of hepatitis C virus by protecting NS5B protein from hPLIC1-dependent proteasomal degradation. Journal of Biological Chemistry, 294(15), 5759-5773.
  12. Sanada, T., Tsukiyama-Kohara, K., Shin-I, T., Yamamoto, N., Kayesh, M. E. H., Yamane, D., ... & Kohara, M. (2019). Construction of complete Tupaia belangeri transcriptome database by whole-genome and comprehensive RNA sequencing. Scientific reports, 9(1), 12372.
  13. Tokunaga, Y., Osawa, Y., Ohtsuki, T., Hayashi, Y., Yamaji, K., Yamane, D., ... & Kohara, M. (2017). Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model. Scientific reports, 7(1), 325.
  14. Tsukiyama-Kohara, K., & Kohara, M. (2017). Hepatitis C virus: viral quasispecies and genotypes. International journal of molecular sciences, 19(1), 23.
  15. Kouwaki, T., Fukushima, Y., Daito, T., Sanada, T., Yamamoto, N., Mifsud, E. J., ... & Oshiumi, H. (2016). Extracellular vesicles including exosomes regulate innate immune responses to hepatitis B virus infection. Frontiers in Immunology, 7, 335.
  16. Katsume A, Tokunaga Y, Hirata Y, Munakata T, Saito M, Hayashi H, Okamoto Y, Kusanagi I, Fujiwara S, Tsukada T, Aoki Y, Klumpp K,Tsukiyama-Kohara K,El-Gohary A, Sudoh M, Kohara M. A serine palmytoiltransferase inhibitor inhibits hepatitis C virus replication in human hepatocytes.Gastroenterologydoi:pii: S0016-5085(13)00914-1. 10.1053.
  17. Tsukiyama-KoharaK*,Katsume A, Kimura K, Saito M, Kohara M. 4E-BP1 regulates the differentiation of white adipose tissue.Genes Cells. Jul;18(7):602-607, 2013.
  18. Nakagawa S, Hirata Y, Kameyama T, Tokunaga Y, Nishito Y, Hirabayashi K, Yano J, Ochiya T, Tateno C, Tanaka Y, Mizokami M,Tsukiyama-KoharaK,Inoue K, Yoshiba M, Takaoka A, Kohara M.Targeted induction of interferon-λ in humanized chimeric mouse liver abrogates hepatotropic virus infection.PLoS One. 8(3) e59611, 2013.
  19. Salem NE, Saito M, Kasama Y, Ozawa M, Kawabata T, Harada S, Suda H, Asonuma K, El-Gohary A,Tsukiyama-Kohara K.Genomic polymorphisms in 3β-hydroxysterol Δ24-reductase promoter sequences.Microbiol Immunol.Mar;57(3) 179-184, 2013.
  20. Sekiguchi S, Kimura K, Chiyo T, Ohtsuki T, Tobita Y, Tokunaga Y, Yasui F,Tsukiyama-Kohara K,Wakita T, Tanaka T,Miyasaka M, Mizuno K, Hayashi Y, Hishima T, Matsushima K and Kohara M. Immunization with a recombinant vaccinia virus that encodes nonstructural proteins of the hepatitis C virus suppr esses viral protein levels in mouse liver.Pros One, 7(12) e51656, 2012.
  21. Tsukiyama-Kohara K.Role of Oxidative stress in hepatocarcinogenesis induced by hepatitis C virus.Int. J. Mol. Sci. 13, 15271-15278,2012.
  22. Inoue K,Tsukiyama-Kohara K,Matsuda C, Yoneyama M, Fujita T, Kuge S, Yoshiba M, and Kohara M. Impairment of interferon regulatory factor-3 activation by hepatitis C virus core protein basic amino acid region 1.Biochem. Biophys. Res. Com.30;428(4) 494-499, 2012.
  23. Saitou M, Kohara, M,Tsukiyama-Kohara K*.Hepatitis C virus promotes expression of the 3β-hydroxysterol Δ24-reductase through Sp1.J. Med. Virol., 84: 733-746 (2012).
  24. Kasama Y, Saito M, Takano T, Nishimura T, Satoh M, Wang Z,Nagla. E S, Harada S, Kohara M,Tsukiyama-Kohara K*.Translocase of outer mitochondrial membrane 70 induces interferon response and is impaired by hepatitis C virus NS3. Virus Res., 163: 405-409 (2012).
  25. Satoh M, Saito M, Takano T, Kasama Y, Nishimura T, Nishito Y, Hirata Y, Arai M, Sudoh M, Kai C, Kohara M,Tsukiyama-Kohara K*.Monoclonal antibody 2-152a suppresses hepatitis C virus infection thoroughbetaine/GABA transporter-1.J. Infect. Dis.,204(8):1172-1180 (2011).
  26. Takano T,Tsukiyama-Kohara K*, Hayashi M, Hirata Y, Satoh M, Tateno C, Hayashi Y, Hishima T, Funata N, Sudo M, and Kohara M.Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes..J. Hepatology55(3) 512-521 (2011).
  27. Takano T, Kohara M, Kasama Y, Nishimura T, Saito M, Kai C,Tsukiyama-Kohara K*. Translocase of outer mitochondrial membrane 70 expression is induced by hepatitis C virus and is related to the apoptotic response.J. Med. Virol.,83, 801-809 (2011).
  28. Tsukiyama-Kohara K*, Sekiguchi S, Kasama Y, Nagla ES, Machida K, Kohara M. Hepatitis C virus-related lymphomagenesis in a mouse model. ISRNHematology,2011: 167501 (2011).
  29. Kasama Y, Satoh M, Saito M, Okada S, Kai C, andTsukiyama-Kohara K*.Potential of a recombinant measles virus as expression vector of hepatitis C virus envelope proteins.World J. Vaccine.1 98-103 (2011).
  30. Kasama Y, Sekiguchi S, Saito M, Tanaka K, Satoh M, Kuwahara K, Sakaguchi N, Takeya M, Hiasa Y, Kohara M,Tsukiyama-Kohara K.Persistent expression of the full genome of hepatitis C virus in B cells inducesspontaneous development of B-cell lymphomasin vivo. Blood116(23):4926-4933, 2010.
  31. Satoh M, Saito M, Tanaka K, Iwanaga S, Salem NE, Seki T, Okada S, Kohara M, Harada S, Kai C,Tsukiyama-Kohara K.Evaluation of a recombinant measles virus expressing hepatitis C virus envelope proteins by infection of human PBL-NOD/Scid/Jak3null mouse.Comp. Immunol. Immunopathol.33 E81-88, 2010.
  32. Amako Y,Tsukiyama-Kohara K, Katsume A, Hirata Y, Sekiguchi S, Tobita Y, Hayashi Y, Hishima T, Funata N, Yonekawa H, Kohara M. Pathogenesis of hepatitis C virus infection inTupaia belangeri.J. Virology84 303-311, 2010.
  33. Nishimura T, Kohara M, Izumi K, Kasama Y, Hirata Y, Huang Y, Shuda M, Mukaidani C, Takano T, Tokunaga Y, Nuriya H, Satoh M, Saito M, Kai C. andTsukiyama-Kohara K.HEPATITIS C VIRUS IMPAIRS P53 VIA PERSISTENT OVER-EXPRESSION OF 3ß-HYDROXYSTEROL∆24-REDUCTASEJ. Biol. Chem.284 36442-36452, (2009)
  34. K. Saitou, K. Mizumoto, T. Nishimura, C. Kai andK. Tsukiyama-Kohara. Hepatitis C virus core protein facilitates the degradation of Ku70 and reduces DNA-PK activity in hepatocytes.Virus Research144 266-271, (2009).
  35. Keigo Machida,Kyoko Tsukiyama-Kohara, Eiji Seike, Shigenobu Tóne, Yukiko Hayashi, Yuri Kasama, Masumi Shimizu, Hidemi Takahashi, Chyoji Taya, Hiromichi Yonekawa, Nobuyuki Tanaka, and Michinori Kohara. Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins.Gastroenterology(2009) 137:285-296, (2009).
  36. Inhibition of host protein synthesis in B95a cells infected with the HL strain of measles virus. Y. Inoue,K. Tsukiyama-Kohara,M. Yoneda, H. Sato, and *C. Kai.Comp. Immunol. Microbiol. Infect. Dis. 32 (1):29-41, (2009).
  37. Comparative Aspects on the Role of Polypyrimidine Tract Binding Protein in Internal Initiation of Hepatitis C Virus and Picornavirus RNAs. T.Nishimura, M.Saito, T.Takano, A. Nomoto, M. Kohara, andK. Tsukiyama-Kohara.Comp. Immunol. Microbiol. Infect. Dis. (5):435-48 (2008).
  38. ATF4-Mediated Induction of 4E-BP1 Contributes to Pancreatic ß Cell Survival under Endoplasmic Reticulum Stress. S. Yamaguchi, *H. Ishihara, T. Yamada, A. Tamura, M. Usui, R. Tominaga, Y. Munakata, C. Satake, H. Katagiri, F. Tashiro, H. Aburatani,K. Tsukiyama-Kohara,J. Miyazaki, N. Sonenberg and Y. Oka.Cell Metabolism7(3):269-76 (2008).
  39. Measles virus induces cell-type specific changes in gene expression. H. Sato, R. Honma, M.Yoneda, R. Miura, K. Tsukiyama-Kohara, F. Ikeda, T. Seki, S.Watanabe, and *C. Kai.Virology5;375(2):321-330 (2008).
  40. Heparin-like glycosaminoglycans prevent the infection of measles virus in SLAM-negative cell lines. Y. Terao-Muro, M. Yoneda, T. Seki, A. Watanabe,K. Tsukiyama-Kohara,K.Fujita, and *C. Kai.Antiviral Res. 80(3) 370-376 (2008).


Profile Details

https://ris.kuas.kagoshima-u.ac.jp/html/100005573_en.html
https://loop.frontiersin.org/people/505142/network
https://www.researchgate.net/profile/Kyoko-Tsukiyama-Kohara-2
https://www.ws-virology.org/dt_team/kyoko-tsukiyama-kohara/

Free SCIRP Newsletters
Copyright © 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.
Top